|
1.
|
Seoane J, Aguirre-Urizar JM, Esparza-Gomez
G, Suarez-Cunqueiro M, Campos-Trapero J and Pomareda M: The
spectrum of plasma cell neoplasia in oral pathology. Med Oral.
8:269–280. 2003.(In English).
|
|
2.
|
Dinter DJ, Neff WK, Klaus J, Bohm C,
Hastka J, Weiss C, Schoenburg SO and Metzgeroth G: Comparison of
whole-body MR imaging and conventional X-ray examination in
patients with multiple myeloma and implications for therapy. Ann
Hematol. 88:457–464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Mulligan ME and Badros AZ: PET/CT and MR
imaging in myeloma. Skeletal Radiol. 36:5–16. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Beers MH, Porter RS, Jones TV, Kaplan JL
and Berkwits M: The Merck Manual of Diagnosis and Therapy. 18th
edition. Merck Research Laboratories; Whitehouse Station, NJ: pp.
1129–1131. 2006
|
|
5.
|
Dores GM, Landgren O, McGlynn KA, Curtis
RE, Linet MS and Devesa SS: Plasmacytoma of bone, extramedullary
plasmacytoma, and multiple myeloma: incidence and survival in the
United States, 1992–2004. Br J Hematol. 144:86–94. 2009.
|
|
6.
|
Kyle RA, Gertz MA, Witzig TE, Lust JA,
Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar V, Offord JR, Larson
DR, et al: Review of 1027 patients with newly diagnosed multiple
myeloma. Mayo Clin Proc. 78:21–33. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Mai Y, Qiu L and Li R: The clinical and
laboratory features of 432 patients with multiple myeloma. J Leuk
Lymphoma. 13:198–201. 2004.
|
|
8.
|
Durie BG, Kyle RA, Belch A, Bensinger W,
Blade J, et al: Myeloma management guidelines: a consensus report
from the Scientific Advisors of the International Myeloma
Foundation. Hematol J. 4:379–398. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Greipp PR, San Miguel J, Durie BG, et al:
International staging system for multiple myeloma. J Clin Oncol.
23:3412–3420. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
International Myeloma Working Group:
Criteria for the classification of monoclonal gammopathies,
multiple myeloma and related disorders: a report of the
International Myeloma Working Group. Br J Haematol. 121:749–757.
2003. View Article : Google Scholar
|
|
11.
|
Bird JM, Owen RG, D’Sa S, Snowden JA,
Pratt G, et al: Guidelines for the diagnosis and management of
multiple myeloma 2011. Br J Haematol. 154:32–75. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Nau KC and Lewis WD: Multiple myeloma:
diagnosis and treatment. Am Fam Physician. 78:853–859.
2008.PubMed/NCBI
|
|
13.
|
Ashcroft AJ, Davies FE and Morgan GJ:
Aetiology of bone disease and the role of bisphosphonates in
multiple myeloma. Lancet Oncol. 4:284–292. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Epstein JB, Emerton S, Guglietta A and Le
N: Assessment of epidermal growth factor in oral secretions of
patients receiving radiation therapy for cancer. Oral Oncol.
33:359–363. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Mozaffari E, Mupparapu M and Otis L:
Undiagnosed multiple myeloma causing extensive dental bleeding:
report of a case and review. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 94:448–453. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Pinto LS, Campagnoli EB, Leon JE, et al:
Maxillary lesion presenting as a first sign of multiple myeloma:
case report. Med Oral Patol Oral Cir Bucal. 12:E344–E347.
2007.PubMed/NCBI
|
|
17.
|
Shah A, Ali A, Latoo S and Ahmad I:
Multiple Myeloma presenting as Gingival mass. J Maxillofac Oral
Surg. 9:209–212. 2010. View Article : Google Scholar
|
|
18.
|
Zachriades N, Papanicolaou S,
Papavassiliou D, Vairaktaris E, Triantafyllou D and Mezitis M:
Plasma cell myeloma of the jaws. Int J Oral Maxillofac Surg.
16:510–515. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Pisano JJ, Coupland R, Chen SY and Miller
AS: Plasmacytoma of the oral cavity and jaws: a clinicopathologic
study of 13 cases. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 83:265–271. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Hsi ED and Yegappan S: Lymphoma
immunophenotyping: a new era in paraffin-section
immunohistochemistry. Adv Anat Pathol. 8:218–239. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Bayer-Garner IB, Prieto VG and Smoller BR:
Detection of clonality with κ and λ immunohistochemical analysis in
cutaneous plasmacytomas. Arch Pathol Lab Med. 128:645–648.
2004.
|
|
22.
|
Durie BG and Salmon SE: A clinical staging
system for multiple myeloma. Correlation of measured myeloma cell
mass with presenting clinical features, response to treatment, and
survival. Cancer. 36:842–854. 1975. View Article : Google Scholar : PubMed/NCBI
|
